Aastrom Biosciences Inc
ASTM
Log in to follow and get free email alerts when insiders file.
Sector
Biological Products, Except Diagnostic Substances
Industry
Drugs
Recent Filings - SEC Insider Transactions (Form 3,4,5)
File Date | Date | Company | Filer | Security | Shares | Price | $ Total | % Change | 10% | Dir. | Off. | Code | View | SEC | SIC | SIC Group | SIC Division |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buy / Sell (dollars)
1 Month
0%100%
$0.00
avg. $0.00
$531,988.80
avg. $531,988.80
Buy/Sell Ratio
0
Transactions
20
Filers
6
3 Month
35.6%64.4%
$1.04M
avg. $1.04M
$1.88M
avg. $627,456.28
Buy/Sell Ratio
0.552
Transactions
36
Filers
13
12 Month
34.7%65.3%
$1.02M
avg. $1.02M
$1.92M
avg. $159,887.12
Buy/Sell Ratio
0.532
Transactions
45
Filers
22
24 Month
23.3%76.7%
$3.38M
avg. $3.38M
$11.15M
avg. $464,784.85
Buy/Sell Ratio
0.303
Transactions
103
Filers
47
Filers
CIK | Name | Title | Last Transaction | First Transaction | Director | Officer | 10% Own. | Other |
---|---|---|---|---|---|---|---|---|
1313403 | Colangelo Dominick | President and CEO | 2023-02-22 | 2021-03-30 | ||||
1626325 | Hopper Jonathan Mark | Chief Medical Officer | 2023-02-22 | 2021-03-31 | ||||
1841148 | Mara Joseph Anthony Jr | Chief Financial Officer | 2023-02-22 | 2021-04-01 | ||||
1778858 | Halpin Michael | Chief Operating Officer | 2023-02-22 | 2021-07-14 | ||||
1801993 | Flynn Sean C. | VP, General Counsel | 2023-02-22 | 2021-07-16 | ||||
1916145 | SIEGAL JONATHAN | Principal Accounting Officer | 2023-02-22 | 2022-03-11 | ||||
1379970 | GILMAN STEVEN C | 2022-05-02 | 2021-10-28 | |||||
1340228 | Rubino Alan L | 2022-04-29 | 2021-03-22 | |||||
1300997 | Wotton Paul K | 2022-04-29 | 2021-05-13 | |||||
1585084 | Hagen Heidi | 2022-04-29 | 2022-04-29 | |||||
1214938 | MCLAUGHLIN KEVIN F | 2022-04-29 | 2022-04-29 | |||||
1220363 | ZERBE ROBERT L MD | 2022-04-29 | 2022-04-29 | |||||
1865017 | WRIGHT LISA | 2022-04-29 | 2022-04-29 | |||||